NCT04238819 2026-03-02A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including NeuroblastomaEli Lilly and CompanyPhase 1/2 Completed47 enrolled 36 charts
NCT06521567 2025-11-12A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With CancerGlaxoSmithKlinePhase 1/2 Active not recruiting83 enrolled
NCT03330197 2025-08-12A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPGAlaunos TherapeuticsPhase 1/2 Terminated6 enrolled 14 charts
NCT04239092 2025-07-179-ING-41 in Pediatric Patients With Refractory Malignancies.Actuate Therapeutics Inc.Phase 1 Terminated40 enrolled